VYCOR MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
VYCOR MEDICAL, INC. (VYCO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 2.39% for the 12-month period ending 2012-12-31, per its 10-K filed 2013-04-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2013-04-01
- VYCOR MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2012 was 2.39%, a 49.38% increase from fiscal 2011.
- VYCOR MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2011 was 1.60%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month |
|---|---|---|---|
| 2012-12-31 | 2.39% 10-K · filed 2013-04-01 | ||
| 2012-09-30 | 2.39% 10-Q · filed 2012-11-14 | ||
| 2011-12-31 | 1.60% 10-K · filed 2013-04-01 | ||
| 2011-09-30 | 1.60% 10-Q · filed 2012-11-14 | ||
| 2011-06-30 | 1.60% 10-Q · filed 2012-08-14 |